VAISHALIPharmaceuticals
Vaishali Pharma Ltd — PE Ratio & Valuation Analysis
₹4.88
-9.60%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E94.2x100.0% below avg
✅
100.0% Discount to Industry
VAISHALI P/E N/Ax vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹0.06 | ₹17 | 273.3x |
| 2023 | ₹0.59 | ₹18 | 30.8x |
| 2022 | ₹0.38 | ₹14 | 36.3x |
| 2021 | ₹0.10 | ₹4 | 36.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Vaishali Pharma Ltd Valuation
Vaishali Pharma Ltd (VAISHALI) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Historically, VAISHALI has traded at an average PE of 94.2x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
1.52%
Dividend Yield
0.00%
More on Vaishali Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.